12. Transcriptomics and Cancer Risk Assessment

  1. Prof. Dr. Günter Obe2,3,
  2. Dr. Burkhard Jandrig4,
  3. Prof. Dr. Gary E. Marchant5,
  4. Dipl. Päd. Holger Schütz6 and
  5. Prof. Dr. Peter M. Wiedemann7
  1. Wolfgang Kemmner

Published Online: 27 APR 2011

DOI: 10.1002/9783527634613.ch12

Cancer Risk Evaluation: Methods and Trends

Cancer Risk Evaluation: Methods and Trends

How to Cite

Kemmner, W. (2011) Transcriptomics and Cancer Risk Assessment, in Cancer Risk Evaluation: Methods and Trends (eds G. Obe, B. Jandrig, G. E. Marchant, H. Schütz and P. M. Wiedemann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527634613.ch12

Editor Information

  1. 2

    Ret. from University Duisburg-Essen, Germany

  2. 3

    Gershwinstrasse 33, 14513 Teltow, Germany

  3. 4

    Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany

  4. 5

    Arizona State University, Sandra Day O'Connor College of Law, P.O. Box 877906, Tempe, AZ 85287-796, USA

  5. 6

    Research Center Jülich, Institute of Neuroscience and Medicine (INM-8), 52425 Jülich, Germany

  6. 7

    Karlsruher Institut für Technologie (KIT), TAB – Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag, Neue Schönhauser Straße 10, 10178 Berlin, Germany

Author Information

  1. Max Delbrück Center for Molecular Medicine, Experimental and Clinical Research Center (ECRC), Research Group Surgical Oncology, Robert-Rössle-Str. 10, 13125 Berlin, Germany

Publication History

  1. Published Online: 27 APR 2011
  2. Published Print: 20 APR 2011

ISBN Information

Print ISBN: 9783527327539

Online ISBN: 9783527634613

SEARCH

Keywords:

  • biomarker expression;
  • gene expression profiling;
  • genesignature;
  • microarray analysis;
  • Laser microdissection;
  • prognosis;
  • monitoring

Summary

This chapter contains sections titled:

  • Introduction

  • Sample Preparation, Technical Issues, and Data Analysis

  • Conclusions

  • References